Trial Profile
Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycobacterium riyadhense (Primary) ; Tuberculin
- Indications Tuberculosis
- Focus Therapeutic Use
- Sponsors AnHui Longcom Biologic Pharmacy
- 05 Jan 2015 New trial record